WO2008142460A3 - New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii) - Google Patents

New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii) Download PDF

Info

Publication number
WO2008142460A3
WO2008142460A3 PCT/HR2008/000010 HR2008000010W WO2008142460A3 WO 2008142460 A3 WO2008142460 A3 WO 2008142460A3 HR 2008000010 W HR2008000010 W HR 2008000010W WO 2008142460 A3 WO2008142460 A3 WO 2008142460A3
Authority
WO
WIPO (PCT)
Prior art keywords
type
diabetes
prevention
melitusa
treatmant
Prior art date
Application number
PCT/HR2008/000010
Other languages
French (fr)
Other versions
WO2008142460A2 (en
Inventor
Leko Vlado
Original Assignee
Leko Vlado
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leko Vlado filed Critical Leko Vlado
Publication of WO2008142460A2 publication Critical patent/WO2008142460A2/en
Publication of WO2008142460A3 publication Critical patent/WO2008142460A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is dietetic formulation comprising extract from five plant species: centaury plant (Centaurii herba) chicory root (Cichorii radix) nettle plant (Urticaie herba) melissa leaf (Melissae herba) cardoon leaf (Cynara cardunculus) and physiologically acceptable carrier. The formulation is useful for prevention and treatment of both types of diabetes.
PCT/HR2008/000010 2007-05-18 2008-03-20 New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii) WO2008142460A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20070230A HRP20070230B1 (en) 2007-05-18 2007-05-18 Herbal composition for the prevention and treatmentofdiabetes mellitus type (i) and type (ii)
HRP20070230A 2007-05-18

Publications (2)

Publication Number Publication Date
WO2008142460A2 WO2008142460A2 (en) 2008-11-27
WO2008142460A3 true WO2008142460A3 (en) 2009-01-15

Family

ID=46150522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HR2008/000010 WO2008142460A2 (en) 2007-05-18 2008-03-20 New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii)

Country Status (2)

Country Link
HR (1) HRP20070230B1 (en)
WO (1) WO2008142460A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103223016B (en) * 2013-05-06 2014-09-17 长春三德天晟科技有限公司 Ginseng, mulberry leaf and chicoric acid composition for treating diabetes
IT201700040866A1 (en) * 2017-04-12 2018-10-12 Herbal E Antioxidant Derivatives Srl Ed In Forma Abbreviata H&Ad Srl EXTRACTS OF CYNARA SCOLYMUS AND CITRUS AURANTIUM BERGAMIA, THEIR COMBINATIONS AND FORMULATIONS THAT CONTAIN THEM

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055351A1 (en) * 1998-04-23 1999-11-04 Vladimir Leko Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
US20030206976A1 (en) * 1999-03-12 2003-11-06 Vladimir Leko Process and product extracted from herbal composition useful in controlling diabetes mellitus type II
WO2004052299A2 (en) * 2002-12-09 2004-06-24 Shaklee Corporation MODIFICATION OF CYCLOOXYGENASE AND LIPOXYGENASE ACTIVITY WITH ASTERIDAE EXTRACTS AND OPTIONALLy BOSWELLIC ACID
WO2005034973A1 (en) * 2003-10-10 2005-04-21 Vladimir Leko Capsulated herbal composition as auxilary medicament against diabetes mellitus type (i) and (ii)
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
HRP980109B1 (en) * 1998-04-23 2003-02-28 Vladimir Leko Herb mixture and a medicine against diabetes melitus type ii. obtained therefrom

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055351A1 (en) * 1998-04-23 1999-11-04 Vladimir Leko Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
US20030206976A1 (en) * 1999-03-12 2003-11-06 Vladimir Leko Process and product extracted from herbal composition useful in controlling diabetes mellitus type II
WO2004052299A2 (en) * 2002-12-09 2004-06-24 Shaklee Corporation MODIFICATION OF CYCLOOXYGENASE AND LIPOXYGENASE ACTIVITY WITH ASTERIDAE EXTRACTS AND OPTIONALLy BOSWELLIC ACID
WO2005034973A1 (en) * 2003-10-10 2005-04-21 Vladimir Leko Capsulated herbal composition as auxilary medicament against diabetes mellitus type (i) and (ii)
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOLKENT S ET AL: "Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: A morphological and biochemical study", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 99, no. 3, 14 July 2005 (2005-07-14), pages 391 - 398, XP004952620, ISSN: 0378-8741 *
LEE ET AL: "Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 115, no. 2, 19 December 2007 (2007-12-19), pages 263 - 270, XP022393930, ISSN: 0378-8741 *
SARA K SWANSTON-FLATT ET AL: "Glycaemic effects of traditional european plant treatments for diabetes.Studies in normal and streptozotocin diabetic mice", DIABETES RESEARCH, TEVIOT-KIMPTON PUBLICATIONS, EDINBURGH, GB, vol. 10, no. 3, 1 March 1989 (1989-03-01), pages 69 - 73, XP002112023, ISSN: 0265-5985 *

Also Published As

Publication number Publication date
HRP20070230B1 (en) 2010-05-31
HRP20070230A2 (en) 2008-11-30
HRP20070230A9 (en) 2008-12-31
WO2008142460A2 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
Ng et al. Effect of in vitro digestion on the total polyphenol and flavonoid, antioxidant activity and carbohydrate hydrolyzing enzymes inhibitory potential of selected functional plant‐based foods
Chiou et al. Antioxidant, antidiabetic, and antihypertensive properties of Echinacea purpurea flower extract and caffeic acid derivatives using in vitro models
Lee et al. Anti-influenza A virus effects of fructan from Welsh onion (Allium fistulosum L.)
Przeor Some common medicinal plants with antidiabetic activity, known and available in Europe (A Mini-Review)
Yeap et al. Antihyperglycemic effects of fermented and nonfermented mung bean extracts on alloxan‐induced‐diabetic mice
Zhang et al. Daily supplementation with fresh Angelica keiskei juice alleviates high‐fat diet‐induced obesity in mice by modulating gut microbiota composition
KR101501433B1 (en) A composition for prevention and treatment of non-alcoholic fatty liver disease
WO2007038768A3 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
Olatunji et al. Effect of the polyphenol rich ethyl acetate fraction from the leaves of Lycium chinenseMill. on oxidative stress, dyslipidemia, and diabetes mellitus in streptozotocin‐nicotinamide induced diabetic rats
Petkova et al. Biologically active substances and in vitro antioxidant activity of different extracts from dandelion (Taraxacum officinale) roots.
Petkova et al. Antioxidant activity and fructan content in root extracts from elecampane (Inula helenium L.).
WO2007056133A3 (en) Herbal composition for weight management
Denev et al. Determination of biologically active substances in taproot of common chicory (Cichorium intybus L.)
Takács et al. Wild strawberry, blackberry, and blueberry leaf extracts alleviate starch-induced hyperglycemia in prediabetic and diabetic mice
BRPI0313082B8 (en) "Process for the preparation of echinacea angustifolia root extract and use of the extract thus obtained for the preparation of pharmaceutical or nutraceutical compositions and food supplements".
Derosa et al. The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature
WO2008142460A3 (en) New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii)
Pascoal et al. Impact of onion (Allium cepa L) fructans fermentation on the cecum of rats and the use of in vitro biomarkers to assess in vivo effects
Na et al. Recent trends in anti-obesity and anti-inflammatory studies in modern health care
Park et al. Postprandial hypoglycemic effects of mulberry twig and root bark in vivo and in vitro
WO2010079910A3 (en) Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
WO2011074765A3 (en) Composition including fermented material for oriental medicine as an active ingredient for preventing and treating obesity or hyperlipidemia
WO2009134010A3 (en) Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders
JP2007131605A (en) Indefinite complaint-improving composition and food
DK1768682T3 (en) Plant origin product comprising proanthocyanidins and process for their preparation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08737280

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08737280

Country of ref document: EP

Kind code of ref document: A2